Adma Biologics (ADMA) Amortization - Intangibles (2017 - 2025)
Adma Biologics (ADMA) reported Amortization - Intangibles of $51000.0 for Q4 2025, up 104.0% on a YoY basis from $25000.0 in Q4 2024, and up 34.21% quarter-over-quarter from $38000.0 in Q3 2025.
Adma Biologics (ADMA) Amortization - Intangibles (2017 - 2025) Analysis & Trends
Adma Biologics has reported Amortization - Intangibles for 9 years, with the latest figure at $51000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortization - Intangibles rose 104.0% year-over-year to $51000.0; the trailing twelve-month figure through Dec 2025 stood at $146000.0 (down 62.37% YoY), and the FY2025 full-year result was $144000.0, down 62.89% from the prior year.
- Amortization - Intangibles for Q4 2025 stood at $51000.0, up from $38000.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $224000.0 in Q4 2023, with the low at $25000.0 in Q4 2024.
- Historically, Amortization - Intangibles has averaged $141558.1 across 5 years, with a median of $178919.0 in 2022.
- Annual changes were most pronounced in 2024 — Amortization - Intangibles plunged 88.84% — and 2025, when it soared 104.0%.
- Adma Biologics' Amortization - Intangibles stood at $200000.0 in 2021, then slipped by 10.76% to $178486.0 in 2022, then increased by 25.5% to $224000.0 in 2023, then sank by 88.84% to $25000.0 in 2024, then soared by 104.0% to $51000.0 in 2025.
- The last three Amortization - Intangibles figures came in at $51000.0 (Q4 2025), $38000.0 (Q3 2025), and $32000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | 224,000.00 |
| Sep 30, 2023 | 179,000.00 |
| Jun 30, 2023 | 179,000.00 |
| Mar 31, 2023 | 179,000.00 |
| Dec 31, 2022 | 178,486.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 178,838.00 |
| Mar 31, 2022 | 178,838.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 200,000.00 |